Back to search

The Open University

Epigenetic rewiring in Cerebral Cavernous Malformation disease: the role of Polycomb Repressive Complexes

Abstract

dc:description.abstract

Cerebral cavernous malformation (CCM) is a neuro-vascular disease characterized by capillary-venous malformations composed by enlarged and irregular vessels, almost exclusively located in the central nervous system. Cavernomas are leaky and prone to develop intracerebral hemorrhages and focal neurological deficits. CCM is caused by familial or sporadic mutations in anyone of the three CCM genes (<i>CCM1, CCM2</i> and <i>CCM3</i>). Currently, the only available treatment for CCM patients is surgical resection: an effective pharmacological therapy is missing and urgently needed.<br></br><br></br>Polycomb Repressive Complexes (PRCs) are epigenetic machineries that modulate gene repression. Functional alterations of PRCs have been associated to cancer stem cells epithelial-to-mesenchymal transition in multiple human malignancies. <br></br><br></br>Here I show that PRCs have a key role in driving “endothelial-to-mesenchymal“ transition and formation of CCM lesions, and that their pharmacological inhibition may represent a therapeutic strategy for the treatment of CCM. <br></br><br></br>I found that PRCs reshape the epigenetic landscape of <i>Ccm</i>-null endothelial cells through the repression of multiple sets of genes involved in differentiation, proliferation, inflammation and coagulation, all hallmarks of CCM disease. Then, I analyzed the role played by BMI1 and EZH2, two core subunits of PRCs. Here I report that they regulate the expression of “endothelial-to-mesenchymal” transition genes together with the aberrant proliferative and migratory features shown by <i>Ccm</i>-mutated endothelial cells. Indeed, BMI1 inhibition was effective in rescuing multiple pathological processes causative of CCM disease, both in cell lines, zebrafish and mouse CCM models, with mutations in all the three disease causative genes. <br></br><br></br>My results define a novel role played by epigenetic mechanisms and, in particular, by PRCs in regulating the maintenance of endothelial signaling and the pathological transition through a mesenchymal phenotype. Finally, I showed that the aberrant BMI1 function in CCM can be mitigated with a specific inhibitor, providing a novel therapeutic avenue for this untreatable condition.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Valentino, Mariaelena

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Valentino, Mariaelena. Epigenetic rewiring in Cerebral Cavernous Malformation disease: the role of Polycomb Repressive Complexes. doctoral thesis, The Open University, 2023.